• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18745

【品名】2-amino-2-methylpropanenitrile

【CA登记号】19355-69-2

【 分 子 式 】C4H8N2

【 分 子 量 】84.121

【元素组成】C 57.11% H 9.59% N 33.3%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(II)

3-Trifluoromethyl-4-nitrophenylisocyanate (I) and 2-amino-2-cyanopropane (II) are condensed. After concentration by distillation under reduced pressure and chromatography of the residue on silica gel (elution with dichloromethane: acetone, 8:2 v/v), the intermediate 1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-5-imino-2-imidazolidinone) (III) is obtained. This intermediate, in suspension in aqueous hydrochloric acid, is heated, then cooled and poured into water. The precipitate, filtered, washed and dried, is anandron (RU-23908), which can be recrystallized in an ethanolic medium.

1 Perronet, J.; Girault, P.; Bonne, C. (Aventis Pharma SA); 1-(3-(4-O-Trifluoromethyl-4-(4-O-nitrophenyl)-4,4-dimethyl)imidazolidines. DE 2649925; ES 452746; FR 2329276; FR 7533084; GB 1518444; JP 52057176; US 4097578 .
2 Ojasoo, T.; Nilutamide. Drugs Fut 1987, 12, 8, 763.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28214 4-isocyanato-1-nitro-2-(trifluoromethyl)benzene C8H3F3N2O3 详情 详情
(II) 18745 2-amino-2-methylpropanenitrile 19355-69-2 C4H8N2 详情 详情
(III) 28215 5-imino-4,4-dimethyl-1-[4-nitro-3-(trifluoromethyl)phenyl]-2-imidazolidinone C12H11F3N4O3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(III)

The reaction of 4-cyano-3-(trifluoromethyl)aniline (I) with phosgene afforded isocyanate (II). Subsequent condensation with 2-amino-2-methylpropionitrile (III) in the presence of Et3N in dichloroethane yielded the iminoimidazolidinone (IV), which was hydrolyzed to hydantoin (V) with refluxing 0.5 M HCl. Finally, alkylation with bromoacetonitrile (VI) in the presence of NaH in DMF provided the cyanomethyl compound.

1 Battmann, T.; et al.; Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders. J Steroid Biochem Mol Biol 1998, 64, 1-2, 103.
2 Gaillard-Kelly, M.; Goubet, F.; Philibert, D.; Teutsch, J.-G. (Aventis Pharma SA); Phenylimidazolidines, their process for fabrication, their application as medicaments and the pharmaceutical compsns. containing them. EP 0494819; FR 2671348; JP 1992308579; US 5411981 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18743 4-amino-2-(trifluoromethyl)benzonitrile;5-Amino-2-cyanobenzotrifluoride 654-70-6 C8H5F3N2 详情 详情
(II) 18744 4-isocyanato-2-(trifluoromethyl)benzonitrile C9H3F3N2O 详情 详情
(III) 18745 2-amino-2-methylpropanenitrile 19355-69-2 C4H8N2 详情 详情
(IV) 18746 4-(5-imino-4,4-dimethyl-2-oxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile C13H11F3N4O 详情 详情
(V) 18747 4-(4,4-dimethyl-2,5-dioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile C13H10F3N3O2 详情 详情
(VI) 31883 2-bromoacetonitrile 590-17-0 C2H2BrN 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

The bicyclic nitrile (III) was prepared by reaction of 1,7-dichloroheptan-4-one (I) with 2-aminoisobutyronitrile (II) in the presence of methanolic ammonia (1). Addition of 2-adamantyllithium (IV) to nitrile (III) in Et2O at -50 C furnished ketone (V). Subsequent addition of 4-fluorophenylmagnesium bromide (VI) to ketone (V) in cold THF provided the desired carbinol, which was isolated as the corresponding hydrochloride salt by lyophilization of its solution in aqueous HCl.

1 Oka, M.; et al.; Synthesis and anti-influenza virus activity of tricyclic compounds with a unique amine moiety. Chem Pharm Bull 2001, 49, 4, 379.
2 Kurono, M.; Baba, Y.; Oka, M.; Honda, N.; Matsumoto, Y.; Kakigami, T.; Iwata, N.; Ishiwata, Y.; Ohtuka, T.; Mitani, T.; Sawai, K. (Sanwa Kagaku Kenkyusho Co., Ltd.); Antivirally active N-cycloalkyl alkanol cpds.. EP 0558321; JP 1994048997 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 19913 1,7-dichloro-4-heptanone 40624-07-5 C7H12Cl2O 详情 详情
(II) 18745 2-amino-2-methylpropanenitrile 19355-69-2 C4H8N2 详情 详情
(III) 51398 tetrahydro-1H-pyrrolizine-7a(5H)-carbonitrile C8H12N2 详情 详情
(IV) 51399 2-adamantyllithium C10H15Li 详情 详情
(V) 51400 2-adamantyl[tetrahydro-1H-pyrrolizin-7(5H)-yl]methanone C18H27NO 详情 详情
(VI) 13643 4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide 352-13-6 C6H4BrFMg 详情 详情

合成路线4

该中间体在本合成路线中的序号:(II)

 

1 Belyk, K.M., Morrison, H.G., Jones, P., Summa, V. (Merck & Co., Inc.; Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A.). Potassium salt of an HIV integrase inhibitor. US 2006122205, WO 2006060712, WO 2006060730.
2 Drugs of the Future 2007, 32(2): 118-122
1 Belyk KM, Morrison HG, Jones P, et al. 2006. Potassium salt of an HIV integrase inhibitor. US 2006/0122205 A1 (Merck & Co Inc).
2 Kassahum K. 2006. Use of atazanavir for improving the pharmacokinetics of drugs metabolized by UGT1A1. WO 2006/060731 A2 (Merck & Co Inc).
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18029 Acetone cyanohydrin; 2-Hydroxy-2-methylpropanenitrile; 2-Hydroxy-2-methylpropionitrile; 2-Hydroxyisobutyronitrile; 2-Methyllactonitrile; alpha-Hydroxyisobutyronitrile 75-86-5 C4H7NO 详情 详情
(II) 18745 2-amino-2-methylpropanenitrile 19355-69-2 C4H8N2 详情 详情
(III) 67372 benzyl (2-cyanopropan-2-yl)carbamate 100134-82-5 C12H14N2O2 详情 详情
(IV) 67373 (Z)-benzyl (1-amino-1-(hydroxyimino)-2-methylpropan-2-yl)carbamate   C12H17N3O3 详情 详情
(V) 67374 dimethyl 2-((Z)-(1-amino-2-(((benzyloxy)carbonyl)amino)-2-methylpropylidene)amino)maleate   C18H23N3O6 详情 详情
(VI) 67375 methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate   C17H19N3O6 详情 详情
(VII) 67376 methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate 888504-27-6 C18H21N3O6 详情 详情
(VIII) 67377 benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate 518048-02-7 C24H25FN4O5 详情 详情
(IX) 67378 2-(2-aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide 518048-03-8 C16H19FN4O3 详情 详情
(X) 67379 5-methyl-1,3,4-oxadiazole-2-carbonyl chloride   C4H3ClN2O2 详情 详情
Extended Information